Literature DB >> 26854353

Regulation of Itch and Nedd4 E3 Ligase Activity and Degradation by LRAD3.

Nathaniel C Noyes1, Brian Hampton1, Mary Migliorini1, Dudley K Strickland1.   

Abstract

Itch and Nedd4 are members of the Nedd4 family of E3 ubiquitin ligases that are important in a number of biological processes. Precise regulation of their enzymatic activity is required for normal physiological function. Nedd4-like E3 ligases exist in an inactive form resulting from intramolecular interactions of their catalytic HECT domain with their WW domains. We identified the low-density-lipoprotein receptor class A domain containing 3 (LRAD3), a member of the LDL receptor family, as a potent activator of Itch and Nedd4 as evidenced by their increased auto-ubiquitination when bound to LRAD3. LRAD3 contains two PPxY motifs within its intracellular domain, both of which can bind to the WW domains on Itch and other Nedd4 family members with high affinity. Mutational analysis revealed that binding of Itch to the terminal LRAD3 PPxY motif is required to promote its auto-ubiquitination. We also determined that association of Itch and Nedd4 with LRAD3 leads to increased auto-ubiquitination and subsequent degradation through proteasome-mediated processes. Our findings reveal that LRAD3 is a component of pathways that function effectively to modulate Itch and Nedd4 auto-ubiquitination and levels. The identification of potential ligands for LRAD3 that may modulate LRAD3-induced activation of Itch and Nedd4 is likely to identify additional novel substrates and cellular functions for these important E3 ligases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26854353     DOI: 10.1021/acs.biochem.5b01218

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  ITCH as a potential therapeutic target in human cancers.

Authors:  Qing Yin; Clayton J Wyatt; Tao Han; Keiran S M Smalley; Lixin Wan
Journal:  Semin Cancer Biol       Date:  2020-03-10       Impact factor: 15.707

2.  Phenome-wide Burden of Copy-Number Variation in the UK Biobank.

Authors:  Matthew Aguirre; Manuel A Rivas; James Priest
Journal:  Am J Hum Genet       Date:  2019-07-25       Impact factor: 11.025

3.  Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.

Authors:  Chen Shao; Zhiguo Li; Nihal Ahmad; Xiaoqi Liu
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

Review 4.  Functional Roles of the Interaction of APP and Lipoprotein Receptors.

Authors:  Theresa Pohlkamp; Catherine R Wasser; Joachim Herz
Journal:  Front Mol Neurosci       Date:  2017-03-01       Impact factor: 5.639

5.  Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.

Authors:  Ernest Mangantig; Stuart MacGregor; Mark M Iles; Richard A Scolyer; Anne E Cust; Nicholas K Hayward; Grant W Montgomery; David L Duffy; John F Thompson; Anjali Henders; Lisa Bowdler; Casey Rowe; Gemma Cadby; Graham J Mann; David C Whiteman; Georgina V Long; Sarah V Ward; Kiarash Khosrotehrani; Jennifer H Barrett; Matthew H Law
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

6.  The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.

Authors:  Christophe Le Clorennec; Yassamine Lazrek; Olivier Dubreuil; Christel Larbouret; Marie-Alix Poul; Philippe Mondon; Gerry Melino; André Pèlegrin; Thierry Chardès
Journal:  Oncotarget       Date:  2016-06-14

Review 7.  The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.

Authors:  James A Conway; Grant Kinsman; Edgar R Kramer
Journal:  Genes (Basel)       Date:  2022-03-14       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.